4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001923794-26-000004
Chief Technology Officer sold 7,000 shares at $12.00 ($84,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tyagarajan Seshu · Chief Technology Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-17 | Sale : show line 1 in the form 10b5-1 | −7,000 | $12.00 | $84,000 | 76,865 | D |
| Open-market sales · 7,000 sh · avg $12.00 · $84,000 | ||||||
Loading xslF345X06/ownership.xml…